Correlation between PD-L1 expression and glucose metabolic indexes of 18F-FDG PET/CT imaging of patients with lung adenocarcinoma.

Y Cui, Y Li, X Li - 2018 - Soc Nuclear Med
1244 Objectives: Lung cancer is the malignant tumor with the highest morbidity and mortality
in China. Lung adenocarcinoma is the most common pathological type among lung cancer …

The correlation between PD-L1 expression and metabolic parameters of 18FDG PET/CT and the prognostic value of PD-L1 in non-small cell lung cancer

X Xu, J Li, Y Yang, S Sang, S Deng - Clinical Imaging, 2022 - Elsevier
Objectives In the present study, we aimed to investigate the relationship between metabolic
parameters of 18 F-fluorodeoxyglucose positron emission computed tomography (18 F-FDG …

The impact of PD-L1 on glucose metabolism of lung adenocarcinoma cells

Y Cui, Y Li, X Li - 2018 - Soc Nuclear Med
1252 Objectives: Lung cancer is the malignant tumor with the highest incidence and
mortality in China, among which lung adenocarcinoma is the most common pathological …

[HTML][HTML] Value of 18F-FDG PET/CT Based on PD-L1 to Predict Outcomes of Immunotherapy in NSCLC

F Xie, M Li, X Jing - Advances in Bioscience and Biotechnology, 2023 - scirp.org
Immune checkpoint inhibitors (ICIs), targeting programmed cell death protein-1 (PD-1) and
its ligand (PD-L1), have changed the treatment history of lung cancer, especially in the field …

Predictive value of 18F-FDG PET/CT radiomics for the PD-L1 expression level in lung adenocarcinoma patients

H ZHANG, X MENG, F XIE, Y SONG… - Chinese Journal of …, 2021 - pesquisa.bvsalud.org
Objective: To explore the predictive value of 18F-fluorodeoxyglucose (FDG) PET/CT
radiomics for the programmed death ligand-1 (PD-L1) expression level in lung …

Correlation of PD-L1 high expression with metabolic parameters on total body PET/CT in different specimens with NSCLC

B Hu, H Jin, J Zhang, Y Long, X Wu, Y Gao, J Xu - 2023 - Soc Nuclear Med
P957 Introduction: Total-body positron-emission tomography/computed tomography
(PET/CT, uEXPLORER) has faster scanning speed, higher image quality and lower injected …

PD-L1 in Lung Adenocarcinoma: Insights into the Role of 18F-FDG PET/CT

Y Cui, X Li, B Du, Y Diao, Y Li - Cancer Management and Research, 2020 - Taylor & Francis
Purpose This study aimed to evaluate the role of 18F-fluorodeoxyglucose (18F-FDG)
positron emission tomography (PET)/computed tomography (CT) in expression of tumor …

[HTML][HTML] PD-L1 expression correlation with metabolic parameters of FDG PET/CT and clinicopathological characteristics in non-small cell lung cancer

X Wu, Y Huang, Q Zhao, L Wang, X Song, Y Li… - EJNMMI research, 2020 - Springer
Background Immunotherapy targeting programmed cell death 1 (PD-1) or its ligand 1 (PD-
L1) has shown promising results in non-small cell lung cancer (NSCLC) patients. Exploring …

Correlation of PD-L1 expression on tumor cell and tumor infiltrating immune cell with 18F-fluorodeoxyglucose uptake on PET/computed tomography in surgically …

B Hu, J Xiao, Y Xiu, Z Fu, H Shi… - Nuclear Medicine …, 2020 - journals.lww.com
Objective The uptake of 18 F-fluorodeoxyglucose (18 F-FDG) PET/computed tomography
(CT) is known to be linked to programmed death ligand 1 (PD-L1) expression on tumor cells …

18F-FDG PET metabolic-to-morphological volume ratio predicts PD-L1 tumour expression and response to PD-1 blockade in non-small-cell lung cancer

M Jreige, I Letovanec, K Chaba, S Renaud… - European journal of …, 2019 - Springer
Abstract Purpose Anti-PD-1/PD-L1 blockade can restore tumour-specific T-cell immunity and
is an emerging therapy in non-small-cell lung cancer (NSCLC). We investigated the …